Literature DB >> 2039437

Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.

B D Car1, M Baggiolini, A Walz.   

Abstract

Neutrophil-activating peptide 2 (NAP-2) is generated by cleavage of two inactive precursors, connective-tissue-activating peptide III (CTAP-III) and platelet basic protein (PBP), which are stored in the alpha-granules of blood platelets. Using highly purified CTAP-III as the substrate we studied the generation of NAP-2 by several neutral tissue proteinases. CTAP-III was rapidly cleaved by chymotrypsin, cathepsin G and trypsin, yielding products with neutrophil-stimulating activity. This activity remained unchanged for 24 h in the presence of chymotrypsin, decreased only slowly in the presence of cathepsin G, but was rapidly destroyed by trypsin. CTAP-III was also degraded by human neutrophil elastase and porcine pancreatic elastase, but no active fragments were obtained. By contrast, no degradation of CTAP-III was observed with thrombin, plasmin or 'granzymes' from cytolytic T-lymphocyte granules. Two active fragments of CTAP-III, generated by chymotrypsin or cathepsin G, were purified and partially sequenced, and were found to have the same N-terminal sequence as NAP-2. These results indicate that both proteinases cleave preferentially the bond between amino acids 15 (Tyr) and 16 (Ala) of CTAP-III. We conclude that chymotrypsin-like proteolytic activity in the vicinity of activated platelets may generate NAP-2 intravascularly. Due to its presence in the primary granules of neutrophils and monocytes cathepsin G is likely to be involved in this process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039437      PMCID: PMC1150093          DOI: 10.1042/bj2750581

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

Review 1.  Granzymes: a family of serine proteases in granules of cytolytic T lymphocytes.

Authors:  D E Jenne; J Tschopp
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

2.  Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets.

Authors:  C W Castor; D A Walz; C G Ragsdale; P A Hossler; E M Smith; M C Bignall; B P Aaron; K Mountjoy
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

Review 3.  Cellular models for the detection and evaluation of drugs that modulate human phagocyte activity.

Authors:  M Baggiolini; B Dewald
Journal:  Experientia       Date:  1988-10-15

4.  Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors.

Authors:  J C Kirchheimer; H G Remold
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

5.  A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils.

Authors:  A Walz; M Baggiolini
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

6.  In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes.

Authors:  I Colditz; R Zwahlen; B Dewald; M Baggiolini
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

7.  Expression and secretion of gro/MGSA by stimulated human endothelial cells.

Authors:  D Z Wen; A Rowland; R Derynck
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

8.  Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes.

Authors:  B Dewald; R Rindler-Ludwig; U Bretz; M Baggiolini
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

9.  Neutrophil-activating properties of the melanoma growth-stimulatory activity.

Authors:  B Moser; I Clark-Lewis; R Zwahlen; M Baggiolini
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis.

Authors:  J M Heiple; L Ossowski
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

2.  Biologically active neutrophil chemokine pattern in tonsillitis.

Authors:  C Rudack; S Jörg; F Sachse
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

3.  Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties.

Authors:  M Detheux; L Ständker; J Vakili; J Münch; U Forssmann; K Adermann; S Pöhlmann; G Vassart; F Kirchhoff; M Parmentier; W G Forssmann
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.